Skip to content

Investigation of Clinical Usefulness of All-in-One Peripheral Intravenous Catheter System

Investigation of Clinical Usefulness of All-in-One Peripheral Intravenous Catheter System - Clinical evaluation of all-in-one peripheral intravenous catheter system

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000004638
Enrollment
400
Registered
2010-12-01
Start date
2010-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

not Specified

Interventions

None listed

Sponsors

Nippon Becton Dickinson Company, Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are expected to catheter insertion more than 72 hours Catheter insertion can be done at the back of the hand, forearm, upper arm or leg

Exclusion criteria

Exclusion criteria: Patients who have once enrolled in the Investigation. However, patients who are discharged from the study site during the study period and are again admitted are NOT excluded. Pregnant women Patients who have any one of skin inflammations, burns, other skin lesions and tattoos, etc is at or near a catheter insertion site Patients who have limited insertion sites such as the bending areas of the upper and lower extremities Patients who are in anti-cancer drug therapy Patients who are known their sensitivity to medical adhesive materials like dressing materials Patients who need antibiotics or ointment locally under the dressing material Patients who are perspirating when inserting a catheter Patients who are judged inappropriate to enroll in the Investigation by a physician or a nurse

Design outcomes

Primary

MeasureTime frame
A re-start rate of new catheter and existing one. The re-start rate is defined that a catheter has to be removed due to any reasons including blockage of the catheter, complication such as phlebitis and the like and is replaced with a new catheter.

Secondary

MeasureTime frame
Events including loosening or displacement of securing site or bending or kink of the catheter or phlebitis or infiltration.

Countries

Japan

Contacts

Public ContactTakeshi Tomaru

Nippon Becton Dickinson Company, Ltd. Clinical Development, Medical Affairs

03-6234-5490

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026